Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor
- 25 July 2005
- journal article
- research article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 298 (2), 378-383
- https://doi.org/10.1016/j.ijpharm.2005.03.027
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The blood–brain barrier: an overview: Structure, regulation, and clinical implicationsNeurobiology of Disease, 2004
- Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in miceEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- The potential of chitosan in ocular drug deliveryJournal of Pharmacy and Pharmacology, 2003
- Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor TargetingThe Journal of pharmacology and experimental therapeutics, 2002
- Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the ratEuropean Journal of Neuroscience, 2002
- Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin AInternational Journal of Pharmaceutics, 2001
- Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemiaBritish Journal of Pharmacology, 2001
- Chitosan as a Nasal Delivery System: The Effect of Chitosan Solutions on in Vitro and in Vivo Mucociliary Transport Rates in Human Turbinates and VolunteersJournal of Pharmaceutical Sciences, 1997
- Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriersJournal of Applied Polymer Science, 1997
- The caspase family of cysteine proteasesBritish Medical Bulletin, 1997